Kidney, Pancreas and Liver Allocation and Distribution in the United States

Overview

Journal Am J Transplant

Publisher Elsevier

Specialty General Surgery

Date 2012 Nov 20

PMID 23157207

Citations 31

Authors

J M Smith

S W Biggins

D G Haselby

W R Kim

J Wedd

K Lamb

B Thompson

D L Segev

S Gustafson

R Kandaswamy

P G Stock

A J Matas

C J Samana

E F Sleeman

D Stewart

A Harper

E Edwards

J J Snyder

B L Kasiske

A K Israni

Affiliations

Soon will be listed here.

Abstract

Kidney transplant and liver transplant are the treatments of choice for patients with end-stage renal disease and end-stage liver disease, respectively. Pancreas transplant is most commonly performed along with kidney transplant in diabetic end-stage renal disease patients. Despite a steady increase in the numbers of kidney and liver transplants performed each year in the United States, a significant shortage of kidneys and livers available for transplant remains. Organ allocation is the process the Organ Procurement and Transplantation Network (OPTN) uses to determine which candidates are offered which deceased donor organs. OPTN is charged with ensuring the effectiveness, efficiency and equity of organ sharing in the national system of organ allocation. The policy has changed incrementally over time in efforts to optimize allocation to meet these often competing goals. This review describes the history, current status and future direction of policies regarding the allocation of abdominal organs for transplant, namely the kidney, liver and pancreas, in the United States.

Citing Articles

Present and Future Applications of Artificial Intelligence in Kidney Transplantation.

Kotsifa E, Mavroeidis V J Clin Med. 2024; 13(19).

PMID: 39407999 PMC: 11478249. DOI: 10.3390/jcm13195939.

Retrospective Analysis of the Impact of High- and Low-Quality Donor Livers for Patients with High-Acuity Illness.

Varghese R, Handing G, Montgomery A, Rana A, Goss J Ann Transplant. 2024; 29:e941931.

PMID: 38192097 PMC: 10787593. DOI: 10.12659/AOT.941931.

Debiased lasso for stratified Cox models with application to the national kidney transplant data.

Xia L, Nan B, Li Y Ann Appl Stat. 2023; 17(4):3550-3569.

PMID: 38106966 PMC: 10720921. DOI: 10.1214/23-aoas1775.

A modified Kidney Donor Risk Index for pediatric kidney transplant recipients.

Montgomery A, Goff C, Adeyeri B, Ferreira L, Kamepalli S, Lynn J Pediatr Nephrol. 2022; 38(4):1309-1317.

PMID: 36066770 DOI: 10.1007/s00467-022-05722-y.

Organ allocation in pediatric abdominal transplant.

Ott L, Vakili K, Cuenca A Semin Pediatr Surg. 2022; 31(3):151180.

PMID: 35725055 PMC: 9333194. DOI: 10.1016/j.sempedsurg.2022.151180.

References

Merion R, Schaubel D, Dykstra D, Freeman R, Port F, Wolfe R . The survival benefit of liver transplantation. Am J Transplant. 2005; 5(2):307-13. DOI: 10.1111/j.1600-6143.2004.00703.x. View

Washburn K, Pomfret E, Roberts J . Liver allocation and distribution: possible next steps. Liver Transpl. 2011; 17(9):1005-12. DOI: 10.1002/lt.22349. View

Malinchoc M, Kamath P, Gordon F, Peine C, Rank J, ter Borg P . A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000; 31(4):864-71. DOI: 10.1053/he.2000.5852. View

Heuman D, Abou-Assi S, Habib A, Williams L, Stravitz R, Sanyal A . Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology. 2004; 40(4):802-10. DOI: 10.1002/hep.20405. View

Whiting J, Delmonico F, Morrissey P, Basadonna G, Johnson S, Lewis W . Clinical results of an organ procurement organization effort to increase utilization of donors after cardiac death. Transplantation. 2006; 81(10):1368-71. DOI: 10.1097/01.tp.0000179641.82031.ea. View

Freeman Jr R . MELD/PELD: one year later. Transplant Proc. 2003; 35(7):2425-7. DOI: 10.1016/j.transproceed.2003.08.015. View

McDiarmid S, Anand R, Lindblad A . Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation. 2002; 74(2):173-81. DOI: 10.1097/00007890-200207270-00006. View

Biggins S, Rodriguez H, Bacchetti P, Bass N, Roberts J, Terrault N . Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology. 2005; 41(1):32-9. DOI: 10.1002/hep.20517. View

Hall E, Massie A, James N, Garonzik Wang J, Montgomery R, Berger J . Effect of eliminating priority points for HLA-B matching on racial disparities in kidney transplant rates. Am J Kidney Dis. 2011; 58(5):813-6. DOI: 10.1053/j.ajkd.2011.05.023. View

10.

Zachary A, Braun W . Calculation of a predictive value for transplantation. Transplantation. 1985; 39(3):316-8. DOI: 10.1097/00007890-198503000-00024. View

11.

Washburn K, Edwards E, Harper A, Freeman R . Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system. Am J Transplant. 2010; 10(7):1643-8. DOI: 10.1111/j.1600-6143.2010.03127.x. View

12.

Ojo A, Hanson J, Meier-Kriesche H, Okechukwu C, Wolfe R, Leichtman A . Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol. 2001; 12(3):589-597. DOI: 10.1681/ASN.V123589. View

13.

Chapman J, Bock A, Dussol B, Fritsche L, Kliem V, Lebranchu Y . Follow-up after renal transplantation with organs from donors after cardiac death. Transpl Int. 2006; 19(9):715-9. DOI: 10.1111/j.1432-2277.2006.00337.x. View

14.

Yao F, Ferrell L, Bass N, Watson J, Bacchetti P, Venook A . Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001; 33(6):1394-403. DOI: 10.1053/jhep.2001.24563. View

15.

Freeman Jr R, Wiesner R, Harper A, McDiarmid S, Lake J, Edwards E . The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl. 2002; 8(9):851-8. DOI: 10.1053/jlts.2002.35927. View

16.

Ashby V, Port F, Wolfe R, Wynn J, Williams W, Roberts J . Transplanting kidneys without points for HLA-B matching: consequences of the policy change. Am J Transplant. 2011; 11(8):1712-8. DOI: 10.1111/j.1600-6143.2011.03606.x. View

17.

. Organ Procurement and Transplantation Network--HRSA. Final rule with comment period. Fed Regist. 1998; 63(63):16296-338. View

18.

Wiesner R, Lake J, Freeman R, Gish R . Model for end-stage liver disease (MELD) exception guidelines. Liver Transpl. 2006; 12(12 Suppl 3):S85-7. DOI: 10.1002/lt.20961. View

19.

Grams M, Womer K, Ugarte R, Desai N, Montgomery R, Segev D . Listing for expanded criteria donor kidneys in older adults and those with predicted benefit. Am J Transplant. 2010; 10(4):802-809. PMC: 3146063. DOI: 10.1111/j.1600-6143.2010.03020.x. View

20.

McDiarmid S, Merion R, Dykstra D, Harper A . Selection of pediatric candidates under the PELD system. Liver Transpl. 2004; 10(10 Suppl 2):S23-30. DOI: 10.1002/lt.20272. View